Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Corporativo FraguaB de CVCGSBF 84 Gross Margin % is 23.41% as of Dec. 2024, which is 16% above its 10-year median of 20.14. GuruFocus rates CGSBF with a GF Score™ of 84/100 and a GF Value™ of $44.58. Among 628 Healthcare Providers & Services companies, Corporativo FraguaB de CV ranks worse than 78.5% on this metric.
CGSBF's Gross Margin % is ranked worse than 78.5% of 628
companies
in the Healthcare Providers & Services industry
Industry Median: 40.075
vs CGSBF: 23.41
Corporativo FraguaB de CV had a gross margin of 23.41% for the quarter that ended in Dec. 2024 => Competition eroding margins
Corporativo FraguaB de CV (OTCPK:CGSBF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Corporativo FraguaB de CV had a gross margin of 23.41% for the quarter that ended in Dec. 2024 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Corporativo FraguaB de CV Gross Margin % Related Terms
Corporativo FraguaB de CV Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV Gross Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Corporativo FraguaB de CV's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corporativo FraguaB de CV Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Corporativo FraguaB de CV's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Corporativo FraguaB de CV's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Corporativo FraguaB de CV (CGSBF) has a Gross Margin % of 23.41% as of Dec. 2024. Gross margin is the ratio of total gross profit to net sales. View historical data on Corporativo FraguaB de CV and its competitors. This is 16% above median its historical median of 20.14. Over the past decade, Corporativo FraguaB de CV's Gross Margin % has ranged from 19.23 to 23.41. According to the industry distribution chart, Corporativo FraguaB de CV ranks #493 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 78.5%.
Is Corporativo FraguaB de CV's Gross Margin % too high?
Corporativo FraguaB de CV's current Gross Margin % of 23.41% is 16% above median its 10-year median of 20.14. Over the past 10 years, this metric has ranged from a low of 19.23 to a high of 23.41. The Healthcare Providers & Services industry median Gross Margin % is 40.08. Corporativo FraguaB de CV's value of 23.41% is 41.6% below this industry median. Based on the distribution chart, Corporativo FraguaB de CV ranks #493 out of 628 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Corporativo FraguaB de CV has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Corporativo FraguaB de CV's Gross Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Corporativo FraguaB de CV ranks #493 out of 628 companies for Gross Margin %. This places Corporativo FraguaB de CV in the lower half of its industry. The industry median Gross Margin % is 40.08. Corporativo FraguaB de CV's value of 23.41% is 41.6% below this benchmark. Historically, Corporativo FraguaB de CV's own Gross Margin % has ranged from 19.23 to 23.41 over the past decade. While the company's 10-year median is 20.14 vs. the industry median of 40.08, Corporativo FraguaB de CV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.08, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Corporativo FraguaB de CV's current Gross Margin % of 23.41% is 41.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Corporativo FraguaB de CV and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corporativo FraguaB de CV's current Gross Margin % is 23.41%, which is 16% above median its own 10-year median of 20.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corporativo FraguaB de CV stock overvalued right now?
Corporativo FraguaB de CV (CGSBF) has a current Gross Margin % of 23.41%. The stock's GF Value™ is $44.58, compared to a current price of $29.66 — trading 33.5% below its estimated fair value. The current Gross Margin % is 23.41%, which is 16% above median its 10-year median of 20.14 and 41.6% below the Healthcare Providers & Services industry median of 40.08. Corporativo FraguaB de CV's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Corporativo FraguaB de CV (CGSBF), the current Gross Margin % is 23.41% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Corporativo FraguaB de CV (CGSBF) Overvalued in 2026?
Based on GuruFocus' analysis, Corporativo FraguaB de CV stock appears to be undervalued.
The current stock price of $29.66 is trading 33.5% below its estimated GF Value™ of $44.58.
Key valuation signals for CGSBF:
Gross Margin %: 23.41% (16% above median its 10-year median of 20.14)
GF Value™: $44.58 vs. price of $29.66 (33.5% below fair value)
Industry Position: 41.6% below the Healthcare Providers & Services median (#493 of 628)
No single metric tells the full story. See the CGSBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
84GF Score
Get the complete analysis for CGSBF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGSBF has been successfully added to your 
